Table 2.

Summary variables reflecting the evolution of E, NE, MN, NMN, and NPY in seven pheochromocytoma patients after tumor exclusion.

NRup,1 nmol/LPatientAUC120 min,2 (min · mmol/L)AUMC120 min,3 (min2 · mmol/L)Increase,4 ratioPersistence,5 minPerformance,6 min
E0.5132218 6455.3757.9311
22513930.4156.623
358038 5759.6766.5643
48351641.3862.686
537814 4756.3038.3241
634154385.6815.991
72513200.4252.222
Mean ± SD251 ± 21112 144 ± 13 3714.18 ± 3.5250.0 ± 17.5202 ± 223
NE4177040 4581.6052.584
243824 2090.9155.350
3152883 2003.1854.5173
476833 0531.6043.069
52698103 8755.6238.5216
661313 2851.2821.728
740418 2110.8445.138
Mean ± SD1031 ± 82545 184 ± 34 7482.15 ± 1.7244.4 ± 11.894 ± 72
MN1.4115 480806 85025.8052.11344.8
257533 3450.9658.055.6
3145581 7002.4356.2136.2
423313 2750.3957.122.1
534 0291 861 86356.7254.73103.1
623 530740 80039.2231.51234.7
76729416 87511.2162.0694.8
Mean ± SD11 719 ± 13 152564 958 ± 660 02919.53 ± 21.9253.1 ± 10.0941 ± 1100
NMN11.6110 045582 8007.2258.0419
216 2751 003 70011.6961.7721
310 598598 6507.6156.5430
46030333 2254.3355.3239
544 9022 324 93532.2651.81670
68820348 2506.3439.5250
730 9081 931 36522.2062.51387
Mean ± SD18 225 ± 14 3681 017 561 ± 798 46213.09 ± 10.3255.0 ± 7.8731 ± 574
NPY781149467 5301.5645.270
28411222 1718.7626.4231
38411222 1718.7626.4231
3105948 0031.1045.350
445 254515 66647.1411.4537
57057144 1157.3520.4150
6189841 3501.9821.843
79453313 8059.8533.2327
Mean ± SD10 661 ± 15 648193 234 ± 174 02711.10 ± 16.3029.1 ± 12.8201 ± 181